Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8 USD | +1.27% | +0.25% | +49.81% |
29/03 | Guardion Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
05/02 | North American Morning Briefing : Hopes of March -2- | DJ |
Sales 2024 * | 13.45M 1.12B | Sales 2025 * | 14.8M 1.23B | Capitalization | 10.27M 857M |
---|---|---|---|---|---|
Net income 2024 * | -3M -250M | Net income 2025 * | -3M -250M | EV / Sales 2024 * | 0.76 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.69 x |
P/E ratio 2024 * |
-3.33
x | P/E ratio 2025 * |
-7.84
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.17% |
1 day | +1.27% | ||
1 week | +0.25% | ||
Current month | +1.27% | ||
1 month | -11.80% | ||
3 months | -8.15% | ||
6 months | +29.87% | ||
Current year | +49.81% |
Managers | Title | Age | Since |
---|---|---|---|
Jan Hall
CEO | Chief Executive Officer | - | 19/23/19 |
Chairman | 72 | 30/15/30 | |
Katie Cox
AUD | Comptroller/Controller/Auditor | - | 25/23/25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 30/15/30 | |
Mark Goldstone
BRD | Director/Board Member | 60 | 01/15/01 |
Donald Gagliano
BRD | Director/Board Member | 71 | 09/19/09 |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 8 | +1.27% | 792 |
30/24/30 | 7.9 | -0.25% | 1,610 |
29/24/29 | 7.92 | +0.25% | 8,231 |
26/24/26 | 7.9 | -3.07% | 3,146 |
25/24/25 | 8.15 | +2.13% | 1,833 |
Delayed Quote Nasdaq, May 02, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.81% | 10.27M | |
+33.25% | 699B | |
+26.86% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+15.15% | 236B | |
+5.18% | 198B | |
-10.27% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- GHSI Stock